Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Amrize LtdNYSE: AMRZ
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities rises 118.3% from a year ago
Other current liabilities stood at $906M at the end of Q2 FY2026, up 118.3% from a year earlier and up 14.4% from the prior quarter. Over 3 fiscal years it compounded at +22.4% a year.
Context
- Other current liabilities amounted to 3.7% of total assets at the end of Q2 FY2026, up 1.9 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +118.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 850M USD
- Year-over-year change
- -5.8%
- 3-year CAGR
- +22.4%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 850M | -5.8% |
| FY2024 | 2024-12-31 | 902M | +69.5% |
| FY2023 | 2023-12-31 | 532M | +14.7% |
| FY2022 | 2022-12-31 | 464M | — |
Other Current Liabilities vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's Jun 2026 other current liabilities of $906M is the 2nd highest of the 7 companies compared; the peer median is $617.65M.
- Its year-over-year change of +118.3% is the 2nd highest of 6, against a peer median of +34.0%.
- Other current liabilities amounts to 3.7% of total assets for AMRZ, versus a peer median of 4.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.15B | -32.3% | +13.2% | 2.0% | |
AMRZAmrize Ltd | Jun 2026 | $906M | +118.3% | +22.4% | 3.7% |
| Jun 2026 | $879M | +405.2% | +83.7% | 4.1% | |
| Jun 2026 | $704.3M | +72.7% | +12.9% | 4.3% | |
| Jun 2026 | $531M | -32.2% | +35.2% | 4.2% | |
| Jun 2026 | $475M | +34.0% | -4.4% | 7.6% | |
| Jun 2026 | $27.15M | — | — | 0.7% | |
| Peer median (excluding AMRZ) | $617.65M | +34.0% | +13.2% | 4.1% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.